Navigation Links
Eisai Inc. and the Alzheimer's Association Introduce the C.A.R.E. Pharmacy Award and Call for Nominations

Award Recognizes Critical Role of Pharmacists in Alzheimer's Care

WOODCLIFF LAKE, N.J., June 11 /PRNewswire/ -- Eisai Inc., in coordination with the Alzheimer's Association, today introduces the C.A.R.E. Pharmacy Award (Commitment to Alzheimer's. Recognition of Excellence.), which recognizes the vital role that pharmacists play in helping as many as 5.2 million Americans living with Alzheimer's disease and their 10 million caregivers. With today's announcement, Eisai and the Alzheimer's Association call on people with the disease, and caregivers across America, to nominate local pharmacists for excellence in Alzheimer's disease education and patient care.

Now in its eighth year, the C.A.R.E. Pharmacy Award (formerly the hhc Pharmacy Recognition Award) reflects Eisai's human health care (hhc) mission, which regards patients and their families as the most important participants in the health care process. The C.A.R.E. Pharmacy Award is one way for people with the disease and caregivers to acknowledge the extraordinary efforts of community pharmacists and their impact on the lives of people affected by Alzheimer's disease.

"Alzheimer's is a disease that affects both patients and their caregivers. Eisai's commitment to the patient and caregiver communities is unwavering, and community pharmacists play an integral role in each patient's treatment and care, through ongoing monitoring, counseling and support," said Cynthia Schwalm, President of Eisai Inc. "The C.A.R.E. Pharmacy Award allows us to acknowledge their efforts and showcase best practices in caregiving techniques. We are proud to be working with the Alzheimer's Association to recognize the outstanding efforts of pharmacists who are making a tangible difference in the lives of people affected by Alzheimer's disease."

In addition to being recognized, the winning pharmacist's local Alzheimer's Association chapter will receive a $1,500 donation for its vital support programs. Another $1,500 donation will go to the Alzheimer's Association chapter located in the area from which the most nominations are submitted.

"The Alzheimer's Association is excited to partner with Eisai in recognizing pharmacists who actively participate as part of the team of care providers for those with Alzheimer's disease," said Peter Reed, PhD, senior director of programs for the Alzheimer's Association. "We commend pharmacists who take the time to build a relationship with their patients living with Alzheimer's and their caregivers, helping to educate them about Alzheimer's disease and enhancing the support they receive."

How to Nominate a Pharmacist

Alzheimer's patients and caregivers can nominate pharmacists through September 2008 by visiting To be eligible, nominees must be licensed pharmacists involved in activities within the last year that have helped people with Alzheimer's disease, and these activities must have had a positive effect on patients and/or their families. A full description of the award and nomination criteria can be found at

The winning pharmacist will be selected from the nominee pool by a panel of three judges. One judge is a senior director at the Alzheimer's Association's national office. The second judge is a past winner of this award who worked for 25 years in home care, residential care, group homes, assisted living and long-term care, teaching caregivers and others about Alzheimer's disease. The third judge is the primary caregiver for a parent with Alzheimer's, who understands the challenges and emotions associated with caring for a loved one affected by this disease.

About Eisai Inc.

Eisai Inc. is a U.S. pharmaceutical subsidiary of Eisai Co., Ltd., a research-based human health care (hhc) company that discovers, develops and markets products throughout the world. Eisai focuses its efforts in three therapeutic areas: neurology, gastrointestinal disorders and oncology/critical care. Established in 1995 and ranked among the top-20 U.S. pharmaceutical companies (based on retail sales), Eisai Inc. began marketing its first product in the United States in 1997 and has rapidly grown to become an integrated pharmaceutical business with fiscal year 2007 (year ended March 31, 2008) sales of approximately $3 billion, including the results of the acquisition of MGI PHARMA, Inc.

Eisai Inc. employs approximately 1,500 people at its headquarters in Woodcliff Lake, NJ, at its state-of-the-art pharmaceutical production and formulation research and development facility in Research Triangle Park, NC, and in the field. For more information about Eisai, please visit

About the Alzheimer's Association

The Alzheimer's Association is the leading voluntary health organization in Alzheimer care, support and research. Our mission is to eliminate Alzheimer's disease through the advancement of research; to provide and enhance care and support for all affected; and to reduce the risk of dementia through the promotion of brain health. Our vision is a world without Alzheimer's. For more information, visit

Contact: Suzanne Grogan

Manager, Corporate Communications

Eisai Inc.


Contact: Sue Yeoh

Chandler Chicco Agency


SOURCE Eisai Inc.
Copyright©2008 PR Newswire.
All rights reserved

Related medicine news :

1. Eisai Corporation of North America Announces Appointment of Vice President of U.S. Corporate Communications
2. Alzheimers Research Target May Be a Dead End
3. Statement of Robert OConnor, M.D., M.P.H. Chair, American Heart Association, Emergency Cardiovascular Committee, on U.S. House of Representatives Passage of the Josh Miller HEARTS Act
4. AABB and the Association of Donor Recruitment Professionals Partner to Recognize Blood Donors Worldwide
5. USC physician Anne L. Peters receives American Diabetes Associations Distinguished Clinician Award
6. Pharmacist Associations Partner to Increase the Voice of Pharmacy
7. Photos: The Multiple Sclerosis Association of America Produces a Web Video on the Importance of MRIs
8. Grocery Manufacturers Association: US Food & Drug Administration and European Food Safety Authority Affirm Safety of Certified Food Dyes
9. Association of Medical Illustrators Denounces Orphan Works Bills Before Congress
10. American Diabetes Association Receives $450,000 Grant From Abbott Fund for Latino Community Initiatives
11. Highmark Blue Shield and the Blue Cross Blue Shield Association Name Area Hospitals as 2008 Blue Distinction Centers for Bariatric Care
Post Your Comments:
(Date:11/26/2015)... ... November 26, 2015 , ... ... retro-fused, self-animating trailer titles with ProTrailer: Vintage. This newly styled ProTrailer pack comes ... titles work with any font, giving users limitless opportunities to stylize and create ...
(Date:11/25/2015)... , ... November 25, 2015 , ... ... more aggressive than those found on mammography, according to a study published online ... additional cancers not seen on mammography may necessitate a change in treatment. , ...
(Date:11/25/2015)... MN (PRWEB) , ... November 25, 2015 , ... Finnleo, ... through Christmas Eve on several models of traditional and far-infrared saunas. , ... Nordic Spruce is the most traditional Finnish sauna wood, and Finnleo uses only European ...
(Date:11/25/2015)... ... , ... Dr. John Pierce, Medical Director at the Ageless Forever clinic in ... Capillus272™ Pro laser therapy cap. FDA cleared for safety and efficacy, the Capillus272 offers ... for surgery, prescription pills, or topical foams. , “Capillus272™ Pro is a home-use ...
(Date:11/25/2015)... ... November 25, 2015 , ... For the first time, Vitalalert is ... One Beat ” campaign. The partnership between the two groups began in 2014 with ... International’s cause. , MAP International was founded in 1954 and is an international Christian-based ...
Breaking Medicine News(10 mins):
(Date:11/26/2015)... UTRECHT , Nederland, November 26, 2015 ... --> Een nieuwe aanpak combineert ... van gevorderde kanker. ... -->      (Photo: ... van het Leids Universitair Medisch Centrum (LUMC) ...
(Date:11/26/2015)... , November 26, 2015 3D bioprinting ... 2022, according to a new report by Grand View Research ... Disease (CKD) which demands kidney transplantation is expected to boost ... effective substitute for organ transplantation. --> 3D bioprinting ... 2022, according to a new report by Grand View Research ...
(Date:11/26/2015)... 26, 2015 ... of the  "2016 Future Horizons and ... Surface Testing Market: Supplier Shares, Competitive ... offering.  --> ) ... "2016 Future Horizons and Growth Strategies ...
Breaking Medicine Technology: